Infinite Medical Ventures in conjunction with Centre for Sight launches IMVIS – a futuristic platform enabling fully remote glasses-free 3D eye exams and real-time telemedicine
A revolutionary 3D eye imaging system that’s set to transform eye care, telemedicine, and clinical workflows has been unveiled by Centre for Sight, one of the UK’s leading eye hospitals.
IMVIS (Infinite Medical Ventures Imaging System) digitises the traditional slit lamp exam, a core part of eye examinations that has barely changed in over 100 years.
For the first time, high-definition, fully 3D eye images can now be captured, reviewed and shared remotely – live or retrospectively – on smartphones, tablets, and computers, anywhere in the world.
The system is ready for AI machine learning, creating structured, objective datasets that will power future diagnostic algorithms and smart decision-support tools. IMVIS lays the groundwork for AI-driven healthcare in ophthalmology and is set to slash waiting lists, reduce clinician workload, and improve national and global access to specialist care.
Developed by Sheraz Daya, Medical Director at Centre for Sight, and retinal surgeon Professor Tom Williamson, IMVIS is now in use at Centre for Sight’s East Grinstead and Oxshott centres, with London installations coming soon at Harley Street and London Lauriston Clinic.
“This is a complete digital transformation,” said Sheraz Daya. “IMVIS makes fully remote eye care possible today while creating the clinical infrastructure for AI-driven diagnostics tomorrow. It’s more than an upgrade – it’s a new standard.”
The breakthrough comes as ophthalmology faces rising pressures from ageing populations, limited capacity, and overstretched clinical teams. IMVIS offers a faster, more flexible alternative to the in-person slit lamp exam, enabling documentation, real-time telemedicine, remote collaboration and more efficient patient management.
By producing accurate 3D video imagery at every visit, IMVIS also eliminates the need for outdated clinical drawings and low-quality 2D images. The system’s datasets are perfectly suited for future artificial intelligence integration and medical education, supporting the development of new training models and diagnostic tools. A fundamental goal of the project has been to make the device affordable enough to be implemented by all eye care providers.
“IMVIS will fundamentally change how we deliver eye care,” said Professor Williamson. “It will help reduce waiting times, make eye care more accessible, and open the door to scalable, AI-supported clinical decision-making.”
Centre for Sight has a proven track record of global leadership in eye care innovation, from pioneering LASIK laser eye surgery and ICL lens implantation to introducing gold-standard ophthalmic technologies and advanced corneal treatments. Known for taking on some of the world’s most complex cases, the centre receives international referrals and is regularly trusted with cases deemed untreatable elsewhere.
Founded in 1996 by Sheraz Daya, who has performed over 35,000 cataract procedures and similar number of laser eye procedures, Centre for Sight combines world-class clinical expertise with a patient-first approach. Rated 97% five stars on Trustpilot, the centre is known for its individualised care, safety-first protocols, and around-the-clock patient support.
“This is just the beginning,” added Professor Williamson. “IMVIS will evolve to incorporate AI and reshape how eye care is delivered worldwide.”
IMVIS has been developed in partnership with medical innovation catalyst, Infinite Medical Ventures. Infinite Medical Ventures is a distinct technology development incubator founded by Professor Tom Williamson and Sheraz Daya to take innovative ideas from doctors and clinicians through the process of development all the way to commercialisation.
For more information, visit: https://www.centreforsight.com/ and for more information about IMVIS visit: https://www.infinitemv.com/
